𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Raltitrexed plus weekly oxaliplatin as first-line chemotherapy in metastatic colorectal cancer

✍ Scribed by Daniele Santini; Cristian Massacesi; Rolando Maria D’Angelillo; Fabiana Marcucci; Costantino Campisi; Bruno Vincenzi; Alberta Pilone; Vincenzo Bianco; Maurizio Bonsignori; Giuseppe Tonini


Book ID
111640958
Publisher
Springer US
Year
2004
Tongue
English
Weight
100 KB
Volume
21
Category
Article
ISSN
1357-0560

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Capecitabine plus oxaliplatin (XELOX) ve
✍ Michel Ducreux; Jaafar Bennouna; Mohamed Hebbar; Marc Ychou; Gérard Lledo; Thier 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 440 KB

## Abstract A regimen consisting of 5‐fluorouracil/leucovorin plus oxaliplatin (FOLFOX‐6) is widely used in France in the first‐line treatment of metastatic colorectal cancer (MCRC). The aim of our study was to demonstrate the non‐inferiority of capecitabine plus oxaliplatin (XELOX) __versus__ FOLF